MedTrace Logo

Level of Middle Cranial Fossa Dura in Patients With Cholesteatoma

NCT04551612 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2020-09-17

No results posted yet for this study

Summary

Cholesteatoma is a destructive lesion that progressively expands in the middle ear, mastoid or petrous bone and leads to destruction of the nearby structures. Erosion, which is caused by bone resorption of the ossicular chain and otic capsule, may cause hearing loss, vestibular dysfunction, facial paralysis and intracranial manifestations

Conditions

  • Cholesteatoma, Middle Ear

Interventions

RADIATION

Multislice computed tomography temporal bone

Patients with cholesteatoma will undergo multislice computed tomography (MSCT) temporal bone images. Then The Tegmen level will be determined and compared with the other normal ear at the same patient

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-10-01
Completion
2022-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04551612 on ClinicalTrials.gov